NCT06139315View on ClinicalTrials.gov

A Study to Test How Well Different Doses of BI 765845 Are Tolerated by Healthy People

PHASE1CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

June 2, 2022

Primary Completion Date

June 7, 2023

Study Completion Date

June 7, 2023

Conditions
Healthy
Interventions
DRUG

BI 765845

BI 765845

DRUG

Placebo

Placebo

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06139315 - A Study to Test How Well Different Doses of BI 765845 Are Tolerated by Healthy People | Biotech Hunter | Biotech Hunter